About | Pharmaceutical Chemistry and Sciences Webinar

Welcome to Sciconx Webinars, a leading organizer of premier scientific webinars dedicated to advancing knowledge, fostering collaboration, and driving innovation across various disciplines. At Sciconx Webinars, we believe in the power of bringing together experts, researchers, practitioners, and industry professionals from around the globe to exchange ideas, share insights, and explore new frontiers in science and technology. With a commitment to excellence and a passion for creating impactful events, we strive to provide unparalleled opportunities for learning, networking, and professional development.

Our Mission: Our mission is to facilitate the dissemination of cutting-edge research, promote interdisciplinary collaboration, and inspire the next generation of leaders in science and technology. Through our webinars, we aim to address the most pressing challenges facing society today and drive positive change through innovation and discovery.

Our Vision: We envision a world where scientific knowledge knows no boundaries and where collaboration knows no borders. By fostering a culture of inclusivity, diversity, and excellence, we aim to create a global community of researchers, scholars, and practitioners united in their pursuit of advancing human knowledge and improving the world we live in.

Our Values

Excellence: We strive for excellence in everything we do, from the quality of our webinars to the professionalism of our staff and the satisfaction of our attendees.

Innovation: We embrace innovation as the driving force behind progress and are committed to pushing the boundaries of scientific discovery through creativity and ingenuity.

Integrity: We conduct ourselves with the highest standards of integrity, ethics, and transparency, earning the trust and respect of our stakeholders and partne

Collaboration: We believe in the power of collaboration and actively seek opportunities to foster interdisciplinary partnerships and exchange ideas across diverse fields of study.

Impact: We measure our success not only by the number of attendees at our webinars but also by the real-world impact of the research and collaborations that emerge from our events.

Our Webinars

Sciconx Webinars hosts a diverse portfolio of webinars spanning a wide range of scientific disciplines. One of our flagship events is the International Webinar on Pharmaceutical Chemistry and Science. Welcome to Pharmaceutical Chemistry and Science, hosted by Sciconx Webinars, taking place in February 18, 2025. Join us as we bring together global leaders, esteemed researchers, Pharma professionals, and industry pioneers for a transformative experience dedicated to Innovations in pharma. Under the theme “Advancing the Frontiers of Pharmaceutical Chemistry and Potency” this webinar will explore foster collaboration across disciplines to drive meaningful progress in Pharmaceutical Chemistry and Science. Each webinar is meticulously curated to provide a dynamic platform for researchers, practitioners, policymakers, and industry leaders to come together, share their expertise, and explore new opportunities for collaboration and innovation.

Connect With Us:

We welcome inquiries, feedback, and partnership opportunities. Please feel free to reach out to us at support@sciconx.com or visit our website to learn more about our upcoming webinars, sponsorship opportunities, and how you can get involved. Join us in shaping the future of science. Reserve your spot today! Thank you for your interest in Sciconx Webinars. We look forward to connecting with you and shaping the future of science together.

Latest News

As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage research

2024-10-07 - 2024-12

Pharmaceutical companies are often lambasted for rising drug costs. For example, the price of new drugs entering the US market in 2023 was 35% higher than in 2022. According to an analysis from Reuters, part of the increase is due to a move to develop therapies for rare diseases: because fewer people have those condition, drug makers push up the per-dose price to recover their costs. But the cost of developing drugs for more common diseases, including cancers, is also rising rapidly.

AstraZeneca's £450 Million Vaccine Facility Faces Delays

2025-01-20 - 2025-01

AstraZeneca's planned £450 million investment in a new flu vaccine facility in Speke, Liverpool, has encountered setbacks due to delays in securing government support. Despite urgent warnings from the UK chairman to Business Secretary Jonathan Reynolds after Labour's election victory, early assurances regarding the government's advanced manufacturing plan were not provided promptly. Consequently, the project's timelines were affected, necessitating reworking to meet tight launch projections. The delays have led to frustration with the Whitehall process. The company had been seeking incentives and support to proceed with the investment. With AstraZeneca's significant contribution to the UK's life sciences sector and economy—being the largest private sector investor in UK R&D and employing around 8,700 people—the delays have put pressure on the government to secure private sector investment for economic growth. The government asserts its commitment to supporting innovative medicine development and is in active discussions with AstraZeneca.

AI and Large Language Models Transforming Pharma

2025-01-05 - 2025-01

A recent study highlights the transformative potential of artificial intelligence (AI) and large language models (LLMs) in the pharmaceutical industry. AI applications span various operational areas, including research and development, clinical trials, production, regulatory affairs, and quality control. Machine learning algorithms, in particular, are contributing to advancements in drug discovery and development, offering promising avenues for innovation and efficiency.

Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States

2025-02-14 - 2025-02

Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park) announced on February 14 that it recently unveiled Countmate, a fully automated vial dispensing machine tailored to the unique preferences of the Canada and US market. Unlike Korea, where medications are commonly dispensed in pouch form, the pharmaceutical industry in Canada and US predominantly relies on the vial method, which involves packaging drugs in plastic bottles. With the launch of Countmate, Hanmi aims to strengthen its presence in the region and drive significant growth in its global sales.

Revamping Supply Chains For The Pharmaceutical Industry

2025-02-15 - 2025-02

The Indian pharmaceutical and healthcare industry has played a stellar role in the fight against COVID-19 during the pandemic. From managing the supply chain of nearly two billion vaccine doses in the country, to ensuring seamless vaccine shipments to over 100 nations, supply chains have been at the forefront of the battle against the pandemic. However, the pharmaceutical industry faced significant challenges too such as medicine stock-outs, last-mile service delivery issues, ill-equipped warehousing facilities, shortage of qualified labour etc.

APAC to boost pharmaceutical growth with increased R&D investments

2025-02-17 - 2025-02

South Korea allocated 5.2% of its GDP to R&D in 2024.

Increasing public and private research and development (R&D) investments are expected to strengthen global leadership of Asia-Pacific's developed markets in the pharmaceutical sector, according to BMI.

Governments in developed markets such as Mainland China, Japan, and South Korea are increasing investments to foster an innovative life sciences ecosystem.

International webinar onPharmaceutical Chemistry and Sciences